Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence summary HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS FPKM FPKM max in non-specific A2M CPAMD5, FWP007, S863-7 ENSG00000175899 Alpha-2-macroglobulin 12 9067664-9116229 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002265, CAB017621 Supportive Expressed in all lung: 969.9 ACE ACE1, CD143, DCP1 ENSG00000159640 Angiotensin I converting enzyme 17 63477061-63498380 Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002426, CAB002921, HPA029298 Supportive Group enriched 6 duodenum: 127.7;lung: 50.7;small intestine: 194.5;testis: 45.7 thyroid gland: 17.0 ADIPOQ ACDC, ACRP30, adiponectin, AdipoQ, apM1, GBP28 ENSG00000181092 Adiponectin, C1Q and collagen domain containing 3 186842690-186858463 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB046467, HPA051767 Supportive Tissue enriched 69 adipose tissue: 668.9 salivary gland: 9.7 AGT SERPINA8 ENSG00000135744 Angiotensinogen (serpin peptidase inhibitor, clade A, member 8) 1 230702523-230714297 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001557 Uncertain Tissue enhanced 0 liver: 386.2 cerebral cortex: 109.7 ALB ENSG00000163631 Albumin 4 73397114-73421412 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006262, HPA031024, HPA031025 Supportive Supportive Golgi apparatus, Endoplasmic reticulum Tissue enriched 210 liver: 73775.7 pancreas: 351.6 ALDOC ENSG00000109107 Aldolase C, fructose-bisphosphate 17 28573115-28577264 Cancer-related genes, Candidate cardiovascular disease genes, Cytoskeleton related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003282, CAB020828 Supportive Uncertain Nucleus, Nucleoli, Cytoplasm Tissue enhanced 0 cerebral cortex: 374.3 heart muscle: 93.5 APOA1 ENSG00000118137 Apolipoprotein A-I 11 116835751-116837950 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016778, HPA046715 Supportive Uncertain Vesicles, Cytoplasm Tissue enhanced 0 liver: 8043.6;small intestine: 2701.0 duodenum: 1122.7 APOA2 ENSG00000158874 Apolipoprotein A-II 1 161222292-161223631 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025885 Supportive Tissue enriched 5271 liver: 11107.0 adipose tissue: 2.1 APOA4 ENSG00000110244 Apolipoprotein A-IV 11 116820700-116823306 Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001352, HPA002549, CAB068250, CAB068251, CAB068252 Supportive Supportive Cytoplasm, Centrosome Group enriched 64 duodenum: 1515.1;small intestine: 2145.5 liver: 28.6 APOB ENSG00000084674 Apolipoprotein B 2 21001429-21044073 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016070, HPA049793 Supportive Supportive Cytoplasm, Golgi apparatus, Plasma membrane, Cytoskeleton (Actin filaments) Group enriched 146 duodenum: 144.5;liver: 497.0;small intestine: 246.5 adipose tissue: 2.0 APOC1 ENSG00000130208 Apolipoprotein C-I 19 44914247-44919349 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051518 Supportive Tissue enriched 14 liver: 9774.3 adrenal gland: 714.8 APOC2 ENSG00000234906 Apolipoprotein C-II 19 44946035-44949565 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055877 Supportive Tissue enriched 68 liver: 249.3 tonsil: 3.6 APOE AD2 ENSG00000130203 Apolipoprotein E 19 44905754-44909393 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008363, HPA065539, HPA068768, CAB069921 Supportive Expressed in all liver: 2278.9 APOH B2G1, BG ENSG00000091583 Apolipoprotein H (beta-2-glycoprotein I) 17 66212033-66256525 Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001654, HPA003732, CAB022214 Supportive Supportive Golgi apparatus Tissue enriched 346 liver: 5156.1 kidney: 14.8 APOL1 APOL ENSG00000100342 Apolipoprotein L, 1 22 36253010-36267530 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018885, CAB056156 Supportive Uncertain Cytoplasm Expressed in all urinary bladder: 99.2 BDH1 BDH, SDR9C1 ENSG00000161267 3-hydroxybutyrate dehydrogenase, type 1 3 197509783-197573323 Candidate cardiovascular disease genes, Enzymes, Mitochondrial proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030947, HPA058709 Supportive Supportive Mitochondria, Nucleus but not nucleoli Expressed in all liver: 123.1 C3 ARMD9, C3a, C3b, CPAMD1 ENSG00000125730 Complement component 3 19 6677704-6730562 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003563, CAB004209, HPA020432 Supportive Tissue enriched 6 liver: 2172.5 adipose tissue: 386.5 C4A C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG ENSG00000244731 Complement component 4A (Rodgers blood group) 6 31982024-32002681 Blood group antigen proteins, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB009811, CAB032603, HPA046356, HPA048287, HPA050103 Uncertain Tissue enhanced 0 liver: 152.4 adrenal gland: 32.9 C4B C4B1, C4B3, C4F, CH, CO4, CPAMD3 ENSG00000224389 Complement component 4B (Chido blood group) 6 32014762-32035418 Blood group antigen proteins, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046356, HPA048287, HPA050103 Uncertain Tissue enhanced 0 liver: 168.2 adrenal gland: 38.2 CCL2 GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF ENSG00000108691 Chemokine (C-C motif) ligand 2 17 34255218-34257203 Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013676, HPA019163 Uncertain Expressed in all gallbladder: 255.2 CD40LG CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP ENSG00000102245 CD40 ligand X 136648193-136660390 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045827 Supportive Uncertain Tissue enhanced 0 lymph node: 12.6;tonsil: 12.2 appendix: 6.6 CHGA ENSG00000100604 Chromogranin A (parathyroid secretory protein 1) 14 92923080-92935293 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000023, HPA017369, CAB040544, CAB055506, CAB058688 Supportive Tissue enhanced 0 adrenal gland: 885.3 stomach: 252.0 CHIT1 CHI3, CHIT ENSG00000133063 Chitinase 1 (chitotriosidase) 1 203212827-203273641 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010575 Uncertain Group enriched 16 bone marrow: 27.6;lung: 18.5;lymph node: 20.8 colon: 1.3 CKB CKBB ENSG00000166165 Creatine kinase, brain 14 103519659-103523111 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001254, CAB047313 Supportive Supportive Cytoplasm Expressed in all prostate: 248.2 CKM CKMM ENSG00000104879 Creatine kinase, muscle 19 45306414-45322977 Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047859 Supportive Uncertain Vesicles, Nucleus Tissue enriched 16 skeletal muscle: 18173.4 heart muscle: 1142.4 CLU APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2 ENSG00000120885 Clusterin 8 27596917-27615031 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000476, HPA000572, CAB016253 Uncertain Uncertain Expressed in all cerebral cortex: 5707.2 CP ENSG00000047457 Ceruloplasmin (ferroxidase) 3 149162410-149222055 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001834, CAB008591 Supportive Tissue enriched 29 liver: 481.3 urinary bladder: 16.7 CPB2 CPU, PCPB, TAFI ENSG00000080618 Carboxypeptidase B2 (plasma) 13 46053186-46105076 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004146 Uncertain Tissue enriched 27 liver: 424.2 lung: 15.7 CRP PTX1 ENSG00000132693 C-reactive protein, pentraxin-related 1 159712289-159714589 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005036, HPA027367, HPA027396 Supportive Tissue enriched 5 liver: 625.8 gallbladder: 114.0 CTSB ENSG00000164733 Cathepsin B 8 11842524-11869448 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000457, HPA018156 Uncertain Supportive Vesicles, Nucleoli Expressed in all thyroid gland: 1683.8 CXCL8 3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1 ENSG00000169429 Chemokine (C-X-C motif) ligand 8 4 73740506-73743716 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA057179 Supportive Tissue enriched 8 bone marrow: 1583.5 appendix: 186.6 EDN1 ET1 ENSG00000078401 Endothelin 1 6 12290363-12297194 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA031976, CAB032500, CAB037291 Supportive Uncertain Nucleoli, Golgi apparatus, Nucleus Mixed lung: 26.3 ENG CD105, END, HHT1, ORW, ORW1 ENSG00000106991 Endoglin 9 127815012-127854756 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000096, HPA011862, HPA067440, CAB072873 Supportive Supportive Nucleus but not nucleoli, Cytoplasm Expressed in all spleen: 111.7 ENO2 ENSG00000111674 Enolase 2 (gamma, neuronal) 12 6913745-6923698 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000063, CAB073539 Supportive Tissue enriched 6 cerebral cortex: 215.7 adrenal gland: 37.0 ENO3 ENSG00000108515 Enolase 3 (beta, muscle) 17 4948092-4957131 Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000793 Uncertain Supportive Plasma membrane, Cytoplasm Tissue enriched 15 skeletal muscle: 4404.2 heart muscle: 294.9 EPO EP ENSG00000130427 Erythropoietin 7 100720800-100723700 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB010336, HPA027572 Uncertain Tissue enhanced 0 liver: 2.0 endometrium: 0.9 F12 ENSG00000131187 Coagulation factor XII (Hageman factor) 5 177402140-177409576 Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003825 Uncertain Tissue enriched 143 liver: 111.3 bone marrow: 0.7 F13A1 F13A ENSG00000124491 Coagulation factor XIII, A1 polypeptide 6 6144085-6321013 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001804, CAB002155, HPA047903 Supportive Supportive Plasma membrane, Cytoskeleton (Actin filaments), Nucleus but not nucleoli, Focal Adhesions Expressed in all placenta: 336.6 F13B FXIIIB ENSG00000143278 Coagulation factor XIII, B polypeptide 1 197039191-197067267 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003827, HPA052139 Supportive Tissue enriched 75 liver: 64.6 duodenum: 0.8 F2 ENSG00000180210 Coagulation factor II (thrombin) 11 46719180-46739506 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016780, CAB018650, HPA051476, HPA054698 Supportive Tissue enriched 2559 liver: 514.8 gallbladder: 0.2 F3 CD142 ENSG00000117525 Coagulation factor III (thromboplastin, tissue factor) 1 94529225-94541800 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009438, HPA049292 Uncertain Supportive Vesicles Expressed in all placenta: 90.9 F5 ENSG00000198734 Coagulation factor V (proaccelerin, labile factor) 1 169514166-169586588 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002036 Uncertain Uncertain Golgi apparatus Group enriched 10 gallbladder: 17.9;liver: 71.7;placenta: 40.0 stomach: 4.2 F8 DXS1253E, F8C, FVIII, HEMA ENSG00000185010 Coagulation factor VIII, procoagulant component X 154835788-155026940 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018777 Supportive Expressed in all adipose tissue: 15.0 FABP3 FABP11, H-FABP, MDGI, O-FABP ENSG00000121769 Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) 1 31365625-31376850 Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017830, HPA055754 Supportive Uncertain Golgi apparatus Tissue enriched 7 heart muscle: 2374.1 skeletal muscle: 338.1 FAS APO-1, APT1, CD95, FAS1, TNFRSF6 ENSG00000026103 Fas cell surface death receptor 10 88990531-89015785 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027444 Uncertain Supportive Plasma membrane, Cytoplasm Mixed rectum: 26.9 FGA ENSG00000171560 Fibrinogen alpha chain 4 154583126-154590766 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016776, HPA051370, HPA064755 Supportive Tissue enriched 273 liver: 5995.6 stomach: 21.9 FGB ENSG00000171564 Fibrinogen beta chain 4 154562956-154571086 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001900, HPA001901, CAB008624 Supportive Tissue enriched 371 liver: 6643.0 kidney: 17.8 FGF2 FGFB ENSG00000138685 Fibroblast growth factor 2 (basic) 4 122826708-122898236 Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000125 Uncertain Supportive Nucleus Mixed adipose tissue: 17.4 FGG ENSG00000171557 Fibrinogen gamma chain 4 154604134-154612967 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027529, CAB033120 Supportive Uncertain Tissue enriched 254 liver: 5906.5 gallbladder: 23.2 FN1 CIG, FINC, GFND2, LETS, MSF ENSG00000115414 Fibronectin 1 2 215360440-215436172 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000126, HPA027066 Supportive Tissue enhanced 0 placenta: 2101.5 liver: 721.6 FST FS ENSG00000134363 Follistatin 5 53480409-53487134 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018155, CAB026025 Uncertain Tissue enhanced 0 liver: 31.6 placenta: 20.6 FTH1 FHC, FTH, FTHL6, PIG15, PLIF ENSG00000167996 Ferritin, heavy polypeptide 1 11 61959718-61967660 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB008623, HPA043650 Uncertain Uncertain Cytoskeleton (Microtubules) Expressed in all appendix: 941.1 FTL MGC71996, NBIA3 ENSG00000087086 Ferritin, light polypeptide 19 48965301-48966878 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020769, HPA041602 Supportive Uncertain Cytoplasm Expressed in all kidney: 3106.3 GFAP FLJ45472 ENSG00000131095 Glial fibrillary acidic protein 17 44905008-44916937 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000039, HPA056030, HPA063513 Supportive Supportive Supportive Cytoskeleton (Intermediate filaments) Tissue enriched 1262 cerebral cortex: 1983.8 heart muscle: 1.5 GGT1 CD224, D22S672, D22S732, GGT ENSG00000100031 Gamma-glutamyltransferase 1 22 24583750-24629005 Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045635, HPA047534 Supportive Tissue enhanced 0 kidney: 116.9 duodenum: 54.7 GH1 GH, GH-N, GHN, hGH-N ENSG00000259384 Growth hormone 1 17 63917200-63918838 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA043715 Supportive Tissue enriched 42 placenta: 15.1 endometrium: 0.3 GOT2 KAT4, KATIV, mitAAT ENSG00000125166 Glutamic-oxaloacetic transaminase 2, mitochondrial 16 58707131-58734357 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Mitochondrial proteins, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018139 Supportive Expressed in all skeletal muscle: 189.7 HABP2 FSAP, HABP, HGFAL, PHBP ENSG00000148702 Hyaluronan binding protein 2 10 113550837-113589602 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019518 Uncertain Group enriched 10 gallbladder: 35.6;liver: 167.2 stomach: 10.4 HEXA ENSG00000213614 Hexosaminidase A (alpha polypeptide) 15 72340919-72376476 Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA054583 Uncertain Expressed in all gallbladder: 64.1 HGF DFNB39, F-TCF, HGFB, HPTA, SF ENSG00000019991 Hepatocyte growth factor (hepapoietin A; scatter factor) 7 81699006-81770438 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010333, HPA040360, HPA044088 Uncertain Uncertain Cytoplasm, Centrosome Tissue enriched 13 placenta: 228.9 adrenal gland: 17.0 HP ENSG00000257017 Haptoglobin 16 72054592-72061055 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003787, HPA047750 Supportive Tissue enriched 127 liver: 15456.5 bone marrow: 121.7 HPX ENSG00000110169 Hemopexin 11 6431049-6442617 Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016725 Supportive Tissue enriched 2376 liver: 1577.6 prostate: 0.6 ICAM1 BB2, CD54 ENSG00000090339 Intercellular adhesion molecule 1 19 10270835-10286615 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002126, CAB002142, HPA004877 Supportive Uncertain Plasma membrane, Cytoplasm Expressed in all lung: 116.8 IGF1 IGF-I, IGF1A, IGFI ENSG00000017427 Insulin-like growth factor 1 (somatomedin C) 12 102395867-102480645 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048946 Uncertain Mixed adipose tissue: 62.8 IGFBP1 AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12 ENSG00000146678 Insulin-like growth factor binding protein 1 7 45888357-45893668 Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004445, HPA046972, HPA050640 Supportive Group enriched 5 liver: 416.4;placenta: 211.0 endometrium: 61.8 IL10 CSIF, IL-10, IL10A, TGIF ENSG00000136634 Interleukin 10 1 206767602-206772494 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013120 Uncertain Mixed appendix: 5.2 IL18 IGIF, IL-18, IL-1g, IL1F4 ENSG00000150782 Interleukin 18 11 112143251-112164117 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003980, CAB007772, CAB027385 Supportive Uncertain Nucleus, Golgi apparatus, Cytoplasm Expressed in all skin: 112.1 IL1RL1 DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1 ENSG00000115602 Interleukin 1 receptor-like 1 2 102311502-102352037 Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007406, HPA007917 Uncertain Tissue enriched 10 placenta: 117.3 gallbladder: 11.6 IL1RN ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430 ENSG00000136689 Interleukin 1 receptor antagonist 2 113107214-113134016 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001482, CAB009633 Supportive Tissue enhanced 0 esophagus: 888.1;tonsil: 264.4 bone marrow: 153.1 IL2 IL-2, TCGF ENSG00000109471 Interleukin 2 4 122451470-122456725 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level No evidence Evidence at protein level CAB010310 Uncertain Not detected small intestine: 0.3 IL6 BSF2, HGF, HSF, IFNB2, IL-6 ENSG00000136244 Interleukin 6 7 22725884-22732002 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB023406 Supportive Tissue enhanced 0 adipose tissue: 78.4 urinary bladder: 52.7 IL6ST CD130, GP130 ENSG00000134352 Interleukin 6 signal transducer 5 55935095-55994993 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010558, CAB025784 Uncertain Supportive Plasma membrane, Golgi apparatus Expressed in all placenta: 134.1 INHBA ENSG00000122641 Inhibin, beta A 7 41685114-41703108 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020031 Uncertain Tissue enhanced 0 gallbladder: 20.7 endometrium: 15.1 INS IDDM1, IDDM2 ENSG00000254647 Insulin 11 2159779-2161341 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000048, HPA004932, CAB012098, CAB053843 Supportive Tissue enriched 53 pancreas: 1810.6 skin: 34.1 ITGA2B CD41, CD41B, GP2B, PPP1R93 ENSG00000005961 Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) 17 44372180-44389505 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018611, HPA031168, HPA031169, HPA031170, HPA031171 Supportive Supportive Nucleus but not nucleoli, Cytoplasm Tissue enhanced 0 bone marrow: 9.0 thyroid gland: 2.5 LCN2 24p3, NGAL ENSG00000148346 Lipocalin 2 9 128149071-128153455 Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002695, CAB016549, CAB016550 Supportive Tissue enhanced 0 bone marrow: 1466.7;gallbladder: 2215.8 urinary bladder: 871.6 LEP OB, OBS ENSG00000174697 Leptin 7 128241284-128257628 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010490, CAB016730, HPA030721 Uncertain Tissue enriched 45 adipose tissue: 210.5 placenta: 4.6 LEPR CD295, OBR ENSG00000116678 Leptin receptor 1 65420652-65641559 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030899 Uncertain Uncertain Vesicles Mixed liver: 40.3 LPA LP ENSG00000198670 Lipoprotein, Lp(a) 6 160531483-160664259 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016072, HPA060604 Supportive Tissue enriched 31 liver: 19.7 kidney: 0.6 LPL LIPD ENSG00000175445 Lipoprotein lipase 8 19901717-19967258 Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048749 Uncertain Vesicles Group enriched 9 adipose tissue: 642.2;heart muscle: 196.5 lung: 47.6 LRP1 A2MR, APOER, APR, CD91, LRP, LRP1A ENSG00000123384 Low density lipoprotein receptor-related protein 1 12 57128493-57213351 Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004182, CAB018621, HPA022903 Supportive Supportive Nucleoli, Cytoplasm Expressed in all adipose tissue: 77.6 MAPT DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau ENSG00000186868 Microtubule-associated protein tau 17 45894382-46028334 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000151, HPA069524, HPA069570 Supportive Tissue enhanced 0 cerebral cortex: 126.4 kidney: 27.0 MB PVALB ENSG00000198125 Myoglobin 22 35606764-35637951 Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000060, HPA003123 Supportive Group enriched 12 heart muscle: 5570.6;skeletal muscle: 9437.8 esophagus: 624.0 MBP ENSG00000197971 Myelin basic protein 18 76978827-77133683 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002300, HPA049222 Supportive Supportive Tissue enriched 37 cerebral cortex: 1427.5 skeletal muscle: 38.9 MME CALLA, CD10, NEP ENSG00000196549 Membrane metallo-endopeptidase 3 155024124-155183729 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000013, HPA052583, HPA056072 Supportive Tissue enhanced 0 duodenum: 291.0;kidney: 235.4;small intestine: 256.5 placenta: 82.8 MMP2 CLG4, CLG4A, TBE-1 ENSG00000087245 Matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) 16 55389700-55506691 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001939, CAB002788 Uncertain Uncertain Cytoplasm, Vesicles Expressed in all gallbladder: 1032.5 MMP3 STMY, STMY1 ENSG00000149968 Matrix metallopeptidase 3 (stromelysin 1, progelatinase) 11 102835801-102843803 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007875 Uncertain Group enriched 7 appendix: 16.7;endometrium: 31.1;urinary bladder: 7.9 stomach: 2.4 MMP9 CLG4B ENSG00000100985 Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) 20 46008908-46016561 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201 Supportive Uncertain Cytoplasm Tissue enhanced 0 bone marrow: 196.2;lymph node: 79.2 appendix: 48.4 MPO ENSG00000005381 Myeloperoxidase 17 58269856-58280935 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000059, HPA021147, HPA061464 Supportive Tissue enriched 273 bone marrow: 2067.0 salivary gland: 7.5 MYH11 SMHC, SMMHC ENSG00000133392 Myosin, heavy chain 11, smooth muscle 16 15703135-15857033 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002302, HPA014539, HPA015310 Supportive Uncertain Plasma membrane, Cytoplasm Tissue enhanced 0 esophagus: 1187.1;smooth muscle: 1186.6 prostate: 900.2 MYH6 ENSG00000197616 Myosin, heavy chain 6, cardiac muscle, alpha 14 23381990-23408277 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001239, HPA001349, CAB075723, CAB075724, CAB075725 Supportive Tissue enriched 10 heart muscle: 827.7 skeletal muscle: 86.6 MYH7 CMD1S, CMH1, MPD1 ENSG00000092054 Myosin, heavy chain 7, cardiac muscle, beta 14 23412738-23435718 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001239, HPA001349, CAB015384 Supportive Group enriched 21 heart muscle: 1767.7;skeletal muscle: 3521.1 prostate: 126.0 MYL2 CMH10 ENSG00000111245 Myosin, light chain 2, regulatory, cardiac, slow 12 110910819-110920722 Candidate cardiovascular disease genes, Cytoskeleton related proteins, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019763, HPA039262 Supportive Uncertain Cytoskeleton (Microtubules) Group enriched 27 heart muscle: 13384.2;skeletal muscle: 7267.8 prostate: 381.0 MYL3 CMH8, MLC1SB, MLC1V, VLC1 ENSG00000160808 Myosin, light chain 3, alkali; ventricular, skeletal, slow 3 46857872-46882169 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016564, CAB018662, HPA046859 Supportive Group enriched 10 heart muscle: 1272.3;skeletal muscle: 1237.8 esophagus: 127.3 NPPA ANP, PND ENSG00000175206 Natriuretic peptide A 1 11845709-11848345 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA058269 Supportive Tissue enriched 1457 heart muscle: 19630.9 pancreas: 13.4 NPPB ENSG00000120937 Natriuretic peptide B 1 11857464-11858931 Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA054960 Uncertain Nucleus, Nucleoli Tissue enriched 2441 heart muscle: 2645.3 testis: 1.0 ORM1 ENSG00000229314 Orosomucoid 1 9 114323056-114326475 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB006265, HPA046438, HPA057726 Uncertain Tissue enriched 62 liver: 5651.0 bone marrow: 91.7 PAPPA ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1 ENSG00000182752 Pregnancy-associated plasma protein A, pappalysin 1 9 116153804-116402322 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001667, CAB016724 Supportive Uncertain Plasma membrane, Cytoplasm Tissue enriched 20 placenta: 67.5 smooth muscle: 3.4 PDGFA PDGF-A, PDGF1 ENSG00000197461 Platelet-derived growth factor alpha polypeptide 7 497258-520296 Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB005579 Uncertain Uncertain Vesicles, Microtubule organizing center Expressed in all lung: 21.1 PDGFB SIS, SSV ENSG00000100311 Platelet-derived growth factor beta polypeptide 22 39223359-39244751 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011604, HPA011972, CAB018341 Supportive Tissue enhanced 0 placenta: 35.1 lung: 19.4 PF4 CXCL4, SCYB4 ENSG00000163737 Platelet factor 4 4 73981077-73982124 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026008, HPA052485 Supportive Tissue enriched 6 bone marrow: 45.8 spleen: 7.8 PGAM1 PGAM-B, PGAMA ENSG00000171314 Phosphoglycerate mutase 1 (brain) 10 97426160-97433441 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042528, HPA049237 Uncertain Expressed in all esophagus: 114.4 PGF D12S1900, PGFL, PLGF, PlGF-2, SHGC-10760 ENSG00000119630 Placental growth factor 14 74941834-74955784 Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA041624 Uncertain Nucleus but not nucleoli, Cytoplasm, Mitochondria Tissue enhanced 0 placenta: 56.4;thyroid gland: 37.1 fallopian tube: 12.6 PLA2G1B PLA2, PLA2A, PPLA2 ENSG00000170890 Phospholipase A2, group IB (pancreas) 12 120322111-120327789 Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047822, HPA060803 Supportive Tissue enriched 405 pancreas: 24344.0 ovary: 60.1 PLA2G7 LDL-PLA2, PAFAH ENSG00000146070 Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) 6 46704201-46735693 Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035916 Uncertain Vesicles Mixed lymph node: 18.7 PLAT ENSG00000104368 Plasminogen activator, tissue 8 42175233-42207724 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003412, CAB009335 Supportive Uncertain Cytoskeleton (Actin filaments) Mixed urinary bladder: 114.6 PLG ENSG00000122194 Plasminogen 6 160702238-160753315 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000668, CAB016678, HPA021602, HPA048823 Supportive Tissue enriched 6 liver: 1009.2 kidney: 171.4 PON1 ESA, PON ENSG00000005421 Paraoxonase 1 7 95297676-95324707 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001610 Uncertain Tissue enriched 53 liver: 111.7 adrenal gland: 2.1 PON2 ENSG00000105854 Paraoxonase 2 7 95404867-95435198 Candidate cardiovascular disease genes, Enzymes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025430, HPA029193 Supportive Expressed in all cerebral cortex: 77.1 PON3 ENSG00000105852 Paraoxonase 3 7 95359944-95396368 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014848, CAB025250 Supportive Tissue enriched 15 liver: 199.5 salivary gland: 13.6 PROC ENSG00000115718 Protein C (inactivator of coagulation factors Va and VIIIa) 2 127418427-127429246 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005550, CAB016721, CAB016792 Supportive Tissue enriched 10 liver: 118.0 kidney: 11.6 PROCR CCD41, CD201, EPCR ENSG00000101000 Protein C receptor, endothelial 20 35172073-35177362 Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039461 Supportive Uncertain Nucleus, Cytoplasm Mixed adipose tissue: 33.5 PROS1 PROS ENSG00000184500 Protein S (alpha) 3 93873033-93974066 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007724, HPA023974 Supportive Uncertain Nuclear membrane, Golgi apparatus Expressed in all liver: 111.3 PROZ PZ ENSG00000126231 Protein Z, vitamin K-dependent plasma glycoprotein 13 113158654-113172383 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052006 Uncertain Group enriched 27 kidney: 12.9;liver: 16.8 testis: 0.5 PRTN3 ACPA, AGP7, C-ANCA, MBT, P29, PR-3 ENSG00000196415 Proteinase 3 19 840960-848175 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005938, CAB017558 Supportive Tissue enriched 846 bone marrow: 981.5 spleen: 1.1 PYGB ENSG00000100994 Phosphorylase, glycogen; brain 20 25248069-25298014 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031067 Uncertain Supportive Plasma membrane, Cytoplasm Expressed in all heart muscle: 85.7 REN ENSG00000143839 Renin 1 204154819-204166322 Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005131, CAB025903 Uncertain Tissue enhanced 0 kidney: 23.3;placenta: 21.8 ovary: 5.4 S100B S100beta ENSG00000160307 S100 calcium binding protein B 21 46598962-46605208 Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000073, HPA015768 Supportive Supportive Vesicles, Nucleus Group enriched 8 adipose tissue: 136.6;cerebral cortex: 309.3 adrenal gland: 28.0 SELE CD62E, ELAM, ELAM1, ESEL ENSG00000007908 Selectin E 1 169722641-169764705 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002143 Supportive Tissue enhanced 0 prostate: 21.6;urinary bladder: 22.4 smooth muscle: 15.7 SELL CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR ENSG00000188404 Selectin L 1 169690667-169711698 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002144 Supportive Tissue enhanced 0 lymph node: 193.3;tonsil: 166.7 spleen: 125.8 SELP CD62, CD62P, GMP140, GRMP, PADGEM, PSEL ENSG00000174175 Selectin P (granule membrane protein 140kDa, antigen CD62) 1 169588849-169630193 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002145, HPA002655, HPA005990 Supportive Supportive Cytoplasm, Nucleus but not nucleoli Mixed urinary bladder: 15.2 SELPLG CD162, PSGL-1 ENSG00000110876 Selectin P ligand 12 108622277-108633959 Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002431 Supportive Expressed in all lymph node: 52.5 SERPINA1 A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1 ENSG00000197249 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 14 94376747-94390693 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000927, HPA001292, CAB013211, CAB016648, CAB073396 Supportive Tissue enriched 20 liver: 11159.4 small intestine: 571.8 SERPINA3 AACT, ACT, alpha-1-antichymotrypsin ENSG00000196136 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 14 94612384-94624055 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000893, HPA002560, CAB016647 Supportive Tissue enriched 10 liver: 407.3 gallbladder: 41.6 SERPINA5 PAI3, PCI, PLANH3, PROCI ENSG00000188488 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 14 94561442-94593120 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA056919, HPA061957 Supportive Uncertain Mitochondria Tissue enhanced 0 adrenal gland: 323.5;liver: 239.7;testis: 454.1 gallbladder: 156.9 SERPINC1 AT3, ATIII, MGC22579 ENSG00000117601 Serpin peptidase inhibitor, clade C (antithrombin), member 1 1 173903804-173917378 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001816, CAB016790, HPA024007 Supportive Tissue enriched 933 liver: 1398.1 kidney: 1.4 SERPIND1 D22S673, HC-II, HC2, HCF2, HLS2 ENSG00000099937 Serpin peptidase inhibitor, clade D (heparin cofactor), member 1 22 20773879-20787720 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008639, HPA055767 Supportive Tissue enriched 191 liver: 389.7 placenta: 2.0 SERPINE1 PAI, PAI1, PLANH1 ENSG00000106366 Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 7 101127089-101139266 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050039 Uncertain Uncertain Cytoplasm Tissue enhanced 0 gallbladder: 334.5;placenta: 276.1 liver: 199.2 SERPINF2 A2AP, AAP, ALPHA-2-PI, API, PLI ENSG00000167711 Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 17 1742836-1755268 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001885, CAB024863 Uncertain Tissue enriched 7 liver: 408.4 kidney: 56.2 SERPING1 C1-INH, C1IN, C1NH, HAE1, HAE2 ENSG00000149131 Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 11 57597387-57614853 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026161, HPA048738 Supportive Expressed in all liver: 1120.0 TFPI EPI, LACI, TFI, TFPI1 ENSG00000003436 Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) 2 187464230-187565760 Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005575, CAB020842 Supportive Uncertain Cytoplasm, Cytoskeleton (Intermediate filaments) Expressed in all placenta: 153.0 TGFB1 CED, DPD1, TGFB, TGFbeta ENSG00000105329 Transforming growth factor, beta 1 19 41301587-41353911 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000361, CAB073543 Uncertain Uncertain Cytoplasm Expressed in all spleen: 53.2 THBD CD141 ENSG00000178726 Thrombomodulin 20 23045633-23049741 Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002425, HPA002982 Supportive Expressed in all lung: 48.3 THBS1 THBS, THBS-1, TSP, TSP-1, TSP1 ENSG00000137801 Thrombospondin 1 15 39581079-39599466 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB033678 Uncertain Tissue enhanced 0 appendix: 365.9 adipose tissue: 276.6 TIMP1 CLGI, EPO, TIMP ENSG00000102265 TIMP metallopeptidase inhibitor 1 X 47582313-47586789 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022360, HPA053417 Supportive Uncertain Golgi apparatus Expressed in all appendix: 1282.3 TIMP2 CSC-21K ENSG00000035862 TIMP metallopeptidase inhibitor 2 17 78852977-78925387 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010203 Uncertain Expressed in all ovary: 802.5 TNFRSF11B OCIF, OPG, TR1 ENSG00000164761 Tumor necrosis factor receptor superfamily, member 11b 8 118923557-118952200 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027013 Uncertain Group enriched 6 kidney: 19.4;thyroid gland: 77.1 endometrium: 8.5 TNFRSF1A CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60 ENSG00000067182 Tumor necrosis factor receptor superfamily, member 1A 12 6328757-6342114 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004102, CAB010309 Uncertain Uncertain Mitochondria Expressed in all gallbladder: 93.6 TNFRSF1B CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80 ENSG00000028137 Tumor necrosis factor receptor superfamily, member 1B 1 12167003-12209228 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004796, CAB013045 Uncertain Expressed in all appendix: 55.6 TNNI3 CMD2A, CMH7, TNNC1 ENSG00000129991 Troponin I type 3 (cardiac) 19 55151767-55157773 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009349, HPA046428, HPA063258 Supportive Uncertain Cytoplasm Tissue enriched 1771 heart muscle: 2776.6 fallopian tube: 1.5 TNNT2 CMD1D, CMH2, CMPD2 ENSG00000118194 Troponin T type 2 (cardiac) 1 201359008-201377762 Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015371, HPA015774, HPA017888 Supportive Uncertain Nucleus, Nucleoli, Cytoskeleton (Microtubules) Tissue enriched 235 heart muscle: 4013.8 urinary bladder: 17.1 TPM1 C15orf13, CMH3 ENSG00000140416 Tropomyosin 1 (alpha) 15 63042632-63071915 Cancer-related genes, Candidate cardiovascular disease genes, Cytoskeleton related proteins, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000261, HPA009066, CAB017698, HPA047089, HPA053624 Supportive Expressed in all heart muscle: 5613.7 VEGFA VEGF, VEGF-A, VPF ENSG00000112715 Vascular endothelial growth factor A 6 43770184-43786487 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005429, CAB039240 Supportive Supportive Mitochondria Expressed in all thyroid gland: 285.9 VTN VN ENSG00000109072 Vitronectin 17 28367276-28373091 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016695, CAB016765, HPA060933 Supportive Tissue enriched 34 liver: 1791.0 gallbladder: 52.8 VWF F8VWF ENSG00000110799 Von Willebrand factor 12 5948874-6124770 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001694, HPA001815, HPA002082, CAB072874, CAB072875 Supportive Mixed adipose tissue: 100.9